Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


US WorldMeds Reaches Agreement With Walgreens To Make Immediately Available LUCEMYRA (lofexidine) In Pharmacies Across The Nation


Benzinga | Aug 31, 2021 09:17AM EDT

US WorldMeds Reaches Agreement With Walgreens To Make Immediately Available LUCEMYRA (lofexidine) In Pharmacies Across The Nation

US WorldMeds, a Kentucky-based specialty pharmaceutical company, announced Walgreens will stock LUCEMYRA (lofexidine) tablets in Walgreens pharmacies across the U.S., effective September 1. LUCEMYRA is the only FDA-approved, non-opioid, non-addictive treatment for relief of multiple symptoms of opioid withdrawal in adults and requires a valid prescription to be dispensed.1 Eligible patients covered by commercial insurance will pay $0* for a LUCEMYRA prescription. Patients without insurance coverage for LUCEMYRA may be eligible to pay $300 for a LUCEMYRA prescription.

According to provisional data released in July by the National Center for Health Statistics, more than 93,000 people died from drug overdoses in 2020, a death toll jump of more than 21,000, or nearly 30%, far eclipsing the record set the prior year.2 More than 900,000 people have died of overdoses since the U.S. drug epidemic began in 1999, according to the Centers for Disease Control and Prevention.3 Overdose deaths involving opioids have continued to drive the death toll, accounting for 69,710 overdose deaths in 2020, up from 50,963 in 2019.2

"LUCEMYRA offers hope for people who want to discontinue opioid use and struggle with the agonizing symptoms of opioid withdrawal," said P. Breckinridge Jones, Chief Executive Officer and founder of US WorldMeds. "US WorldMeds is committed to helping patients in need. We are extremely proud to be partnering with Walgreens, a premier national pharmacy retailer, in support of this vitally important issue."

* Patients whose prescriptions will be paid for in part or in whole by Medicare, Medicaid, or any similar federal or state healthcare program, are not eligible for savings or rebates according to federal and state law. Patients must visit a participating pharmacy for savings or rebates on their LUCEMYRA prescriptions. Maximum benefits may apply.

The actual savings on out-of-pocket costs for LUCEMYRA will vary according to refill quantity, personal healthcare insurance coverage, and adherence to FDA dosing guidelines. For more information about the LUCEMYRA Prescription Savings Co-Pay Assistance Program, please review the Terms and Conditions on LUCEMYRA.com.






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-5
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC